These final results, together with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 aid the strategy of targeting ACKR3 as a unique way to modulate the opioid method, which could open up new therapeutic avenues for opioid-associated